New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
November 3, 2009
07:32 EDTIPXL
theflyonthewall.com: Impax Labs reports Q3 EPS 11c vs. consensus of 5c
Reports Q3 revenue $64.9M vs. consensus $64.2M. :theflyonthewall.com



News For IPXL From The Last 14 Days
Check below for free stories on IPXL the last two weeks.
There are 4 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2012
07:03 EDTIPXL
theflyonthewall.com: Impax provides update on warning letter resolution for Hayward facility
Impax Laboratories provided an update on the status of its resolution of the previously disclosed warning letter issued by the U.S. Food and Drug Administration covering its Hayward manufacturing facility. Late last year, Impax received an acknowledgement letter from the FDA stating that it had received a complete response from Impax to the warning letter. However, a satisfactory re-inspection is required to close out the warning letter and the re-inspection by the FDA has not occurred to date. Therefore, the company's previously stated goal for completing the closing out of the warning letter before the end of February may not occur. Until such re-inspection is completed and the warning letter is closed out, approval of the company's pending drug applications listing the Hayward manufacturing facility as a manufacturing location may be withheld by the FDA. :theflyonthewall.com

February 1, 2012
09:43 EDTIPXL
theflyonthewall.com: Gappers report: Bullish gaps

Subscribe for More Information
:theflyonthewall.com
08:06 EDTIPXL
theflyonthewall.com: Impax licenses exclusive commercialization rights to Zomig from AstraZeneca

Subscribe for More Information
:theflyonthewall.com

January 31, 2012
11:21 EDTIPXL
theflyonthewall.com: Piper Jaffray's biotech and specialty pharma analysts hold a conference call

Subscribe for More Information
:theflyonthewall.com